Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial

Nelson, M.R.Polekhina, G.Woods, R.L.Reid, C.M.Tonkin, A.M.Wolfe, R.Murray, A.M.Kirpach, B.Ernst, M.E.Lockery, J.E.Shah, R.C.Stocks, N.Orchard, S.G.Zhou, Z.2022-04-282022-04-282022Annals of Internal Medicine, 2022; 175(5):1-40003-48191539-3704https://hdl.handle.net/2440/134896LettersAbstract not availableen© 2022 American College of PhysiciansASPREE randomized trialSafety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized TrialJournal article10.7326/M21-38232022-04-27605979Stocks, N. [0000-0002-9018-0361]